Cargando…

Leveraging an Electronic Health Record-Linked Biorepository to Generate a Metformin Pharmacogenomics Hypothesis

Metformin is a first-line antihyperglycemic agent commonly prescribed in type 2 diabetes mellitus (T2DM), but whose pharmacogenomics are not clearly understood. Further, due to accumulating evidence highlighting the potential for metformin in cancer prevention and treatment efforts it is imperative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Breitenstein, Matthew K., Wang, Liewei, Simon, Gyorgy, Ryu, Euijung, Armasu, Sebastian M., Ray, Balmiki, Weinshilboum, Richard M., Pathak, Jyotishman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Informatics Association 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525256/ https://www.ncbi.nlm.nih.gov/pubmed/26306225

Ejemplares similares

Metformin Pharmacogenomics: Biomarkers to Mechanisms
por: Wang, Liewei, et al.
Publicado: (2014)

Pharmacogenomics in Practice
por: Wang, Liewei, et al.
Publicado: (2019)

A cervical cancer biorepository for pharmacogenomics research in Zimbabwe
por: Kuguyo, Oppah, et al.
Publicado: (2022)

Quantifying the impact of chronic conditions on a diagnosis of major depressive disorder in adults: a cohort study using linked electronic medical records
por: Ryu, Euijung, et al.
Publicado: (2016)

Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study
por: Wang, Liewei, et al.
Publicado: (2017)

Leveraging natural history biorepositories as a global, decentralized, pathogen surveillance network
por: Colella, Jocelyn P., et al.
Publicado: (2021)

An electronic medical record-linked biorepository to identify novel biomarkers for atherosclerotic cardiovascular disease
por: Ye, Zi, et al.
Publicado: (2013)

Studying the Confounding Effects of Socio-Ecological Conditions in Retrospective Clinical Research: A Use Case of Social Stress
por: Breitenstein, Matthew K., et al.
Publicado: (2015)

Leveraging multi-source to resolve inconsistency across pharmacogenomic datasets in drug sensitivity prediction
por: Das, Trisha, et al.
Publicado: (2023)

Health behaviors and quality of life predictors for risk of hospitalization in an electronic health record-linked biobank
por: Takahashi, Paul Y, et al.
Publicado: (2015)

Gemcitabine and Arabinosylcytosin Pharmacogenomics: Genome-Wide Association and Drug Response Biomarkers
por: Li, Liang, et al.
Publicado: (2009)

Considerations for automated machine learning in clinical metabolic profiling: Altered homocysteine plasma concentration associated with metformin exposure
por: Orlenko, Alena, et al.
Publicado: (2018)

The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies
por: McCarty, Catherine A, et al.
Publicado: (2011)

Leveraging a national biorepository in Zambia to assess measles and rubella immunity gaps across age and space
por: Carcelen, Andrea C., et al.
Publicado: (2022)

Electronic Health Record Phenotypes for Precision Medicine: Perspectives and Caveats From Treatment of Breast Cancer at a Single Institution
por: Breitenstein, Matthew K., et al.
Publicado: (2018)

Using Clinical Element Models for Pharmacogenomic Study Data Standardization
por: Zhu, Qian, et al.
Publicado: ( 201)

Shared Genetic Etiology of Autoimmune Diseases in Patients from a Biorepository Linked to De-identified Electronic Health Records
por: Restrepo, Nicole A., et al.
Publicado: (2016)

Detecting Associations between Major Depressive Disorder Treatment and Essential Hypertension using Electronic Health Records
por: Pathak, Jyotishman, et al.
Publicado: (2014)

Using Linked Data for Mining Drug-Drug Interactions in Electronic Health Records
por: Pathak, Jyotishman, et al.
Publicado: (2013)

Using Association Rule Mining for Phenotype Extraction from Electronic Health Records
por: Li, Dingcheng, et al.
Publicado: ( 201)

Building biorepositories in the midst of a pandemic
por: Croker, Jennifer A., et al.
Publicado: (2021)

The time is right for an Antarctic biorepository network
por: O’Brien, Kristin M., et al.
Publicado: (2022)

Building blocks for better biorepositories in Africa
por: Croxton, Talishiea, et al.
Publicado: (2023)

Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]
por: Takahashi, Paul Y, et al.
Publicado: (2021)

The Role of the Aryl Hydrocarbon Receptor (AHR) in Immune and Inflammatory Diseases
por: Neavin, Drew R., et al.
Publicado: (2018)

Feasibility of Embedding a Scalable, Virtually Enabled Biorepository in the Electronic Health Record for Precision Medicine
por: DeMerle, Kimberley M., et al.
Publicado: (2021)

CATCH-KB: Establishing a Pharmacogenomics Variant Repository for Chemotherapy-Induced Cardiotoxicity
por: Morash, Maggie, et al.
Publicado: (2018)

Linking pre-existing biorepositories for medical research: the PopGen 2.0 Network
por: Lieb, Wolfgang, et al.
Publicado: (2019)

Metformin Pharmacogenomics: Current Status and Future Directions
por: Pawlyk, Aaron C., et al.
Publicado: (2014)

Bi-directional association between depression and HF: An electronic health records-based cohort study
por: Bobo, William V, et al.
Publicado: (2020)

A model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none?
por: Zhu, Ye, et al.
Publicado: (2020)

Applying semantic web technologies for phenome-wide scan using an electronic health record linked Biobank
por: Pathak, Jyotishman, et al.
Publicado: (2012)

Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases
por: Zhu, Ye, et al.
Publicado: (2019)

The National Gene Vector Biorepository's Pharm/Tox Database
por: Cornetta, Kenneth, et al.
Publicado: (2009)

Harmonisation of maternal health biorepositories in sub-Saharan Africa
por: Russell, Donna
Publicado: (2020)

Barriers to Enrollment in a Pediatric Critical Care Biorepository
por: Paquette, Erin, et al.
Publicado: (2023)

Bias in Recording of Body Mass Index Data in the Electronic Health Record
por: Rea, Susan, et al.
Publicado: ( 201)

Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug Events
por: Zhu, Ye, et al.
Publicado: (2021)

ZNF423 modulates the AMP-activated protein kinase pathway and metformin response in a single nucleotide polymorphisms, estrogen and selective estrogen receptor modulator dependent fashion
por: Qin, Sisi, et al.
Publicado: (2021)

Searching for Pharmacogenomic Markers: The Synergy between Omic and Hypothesis-Driven Research
por: Weinstein, John N.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_3hvfu508714e0d0ge2h97ffslg